We use cookies to improve your experience on our website.  By continuing you are agreeing to our cookie policy.


Sign up for our free newsletter to stay up to date with EdenTree:

The Life Code

Lydia Greasley
By Lydia Greasley Investment Analyst February 2019
Share this insight:
Skip to:
The Life Code

At the cutting edge of medical science

At the cutting edge of medical science  Our role as thought leaders in the responsible investment space is to identify emerging investment opportunities and any attendant ethical issues. The areas covered within our latest Amity Insight: The Life Code, are at the cutting edge of developments in medical science where many of the ethical dilemmas are still to emerge, and to be regulated by policy makers. Consequently, to some degree we too are very early in the process of forming opinions.

However, the application of DNA related knowledge is creating a range of investment opportunities throughout the value chain in diagnostics, genetic editing, research and treatment.

The cutting edge nature of The Life Code does not align perfectly with UN Sustainable Development Goal #3 – Good Health & Wellbeing – which is focussed on conventional approaches to tackling medical inequality via bold commitments. However, Health & Wellbeing in the widest sense is one of EdenTree’s key sustainable themes focussed on improving the efficacy of treatments, reducing drug waste and powering discovery of new drugs for unmet conditions. The Life Code represents an exciting new area of investment exploration and discovery.

Nevertheless, our fairly recent mastery over the building blocks of life pose many unsolved ethical dilemmas. How do we protect this important data? What are the implications of genetic editing that may cause us to contemplate what it really means to be human, and how far should the life code itself be manipulated for profit? We do not have all the answers to these dilemmas, but we do hope you enjoy the voyage of discovery, and as ever, welcome your feedback and comments.

The full copy of the Amity Insight: The Life Code is available by clicking the download button above. 

The value of an investment can fall as well as rise as a result of market and currency fluctuations, you may not get back the amount originally invested. Past performance should not be seen as a guide to future performance. If you are unsure which investment is most suited to you, the advice of a qualified financial adviser should be sought. EdenTree Investment Management Limited (EdenTree) Reg. No. 2519319. Registered in England at Beaufort House, Brunswick Road, Gloucester, GL1 1JZ, United Kingdom. EdenTree is authorised and regulated by the Financial Conduct Authority and is a member of the Investment Association. Firm Reference Number 527473.